Associations between GrimAge acceleration and pulmonary function in the Coronary Artery Risk Development in Young Adults (CARDIA) study

Brian T. Joyce; Xuefen Chen; Tao Gao; Yinan Zheng; Drew R. Nannini; Lei Liu; Benjamin E. Henkle; Ravi Kalhan; George Washko; Ken M. Kunisaki; Bharat Thyagarajan; Douglas E. Vaughan; Myron Gross; David R. Jacobs; Donald Lloyd-Jones; Lifang Hou

doi:10.2217/epi-2023-0164

Associations between GrimAge acceleration and pulmonary function in the Coronary Artery Risk Development in Young Adults (CARDIA) study

Brian T. Joyce, Xuefen Chen, Tao Gao, Yinan Zheng, Drew R. Nannini, Lei Liu, Benjamin E. Henkle, Ravi Kalhan, George Washko, Ken M. Kunisaki, Bharat Thyagarajan, Douglas E. Vaughan, Myron Gross, David R. Jacobs, Donald Lloyd-Jones, Lifang Hou

Research output: Contribution to journal › Article › peer-review

Abstract

Background: The objective of this research was to determine whether pulmonary function is associated with epigenetic aging (GrimAge) and whether GrimAge predicts emphysema. Methods: This prospective study examined 1042 participants enrolled as part of a community-based longitudinal cohort. The cross-sectional associations between pulmonary function and GrimAge, measured at study year (Y) 20 (participant ages 40-45 years), and prospective associations with emphysema at Y25 were examined. Results: At Y20, forced expiratory volume in 1 s (FEV₁) and FEV₁/forced vital capacity (FVC) were negatively associated with GrimAge; for Y0-Y10 cumulative measures, only the FEV₁/FVC ratio was associated with GrimAge at Y15 and Y20. Emphysema at Y25 was associated with GrimAge at Y15 and Y20. Conclusion: Pulmonary function was associated with GrimAge during early and mid-life; GrimAge partially mediated the association between pulmonary function and emphysema.

Original language	English
Pages (from-to)	693-703
Number of pages	11
Journal	Epigenomics
Volume	15
Issue number	13
DOIs	https://doi.org/10.2217/epi-2023-0164
State	Published - Jul 1 2023

Keywords

DNA methylation age
aging
emphysema
lung function
methylation

Access to Document

10.2217/epi-2023-0164

Cite this

Joyce, B. T., Chen, X., Gao, T., Zheng, Y., Nannini, D. R., Liu, L., Henkle, B. E., Kalhan, R., Washko, G., Kunisaki, K. M., Thyagarajan, B., Vaughan, D. E., Gross, M., Jacobs, D. R., Lloyd-Jones, D., & Hou, L. (2023). Associations between GrimAge acceleration and pulmonary function in the Coronary Artery Risk Development in Young Adults (CARDIA) study. Epigenomics, 15(13), 693-703. https://doi.org/10.2217/epi-2023-0164

@article{538bbb2c2a044ddf9bd4827feb194e43,

title = "Associations between GrimAge acceleration and pulmonary function in the Coronary Artery Risk Development in Young Adults (CARDIA) study",

abstract = "Background: The objective of this research was to determine whether pulmonary function is associated with epigenetic aging (GrimAge) and whether GrimAge predicts emphysema. Methods: This prospective study examined 1042 participants enrolled as part of a community-based longitudinal cohort. The cross-sectional associations between pulmonary function and GrimAge, measured at study year (Y) 20 (participant ages 40-45 years), and prospective associations with emphysema at Y25 were examined. Results: At Y20, forced expiratory volume in 1 s (FEV1) and FEV1/forced vital capacity (FVC) were negatively associated with GrimAge; for Y0-Y10 cumulative measures, only the FEV1/FVC ratio was associated with GrimAge at Y15 and Y20. Emphysema at Y25 was associated with GrimAge at Y15 and Y20. Conclusion: Pulmonary function was associated with GrimAge during early and mid-life; GrimAge partially mediated the association between pulmonary function and emphysema.",

keywords = "DNA methylation age, aging, emphysema, lung function, methylation",

author = "Joyce, {Brian T.} and Xuefen Chen and Tao Gao and Yinan Zheng and Nannini, {Drew R.} and Lei Liu and Henkle, {Benjamin E.} and Ravi Kalhan and George Washko and Kunisaki, {Ken M.} and Bharat Thyagarajan and Vaughan, {Douglas E.} and Myron Gross and Jacobs, {David R.} and Donald Lloyd-Jones and Lifang Hou",

note = "Publisher Copyright: {\textcopyright} 2023 Future Medicine Ltd.",

year = "2023",

month = jul,

day = "1",

doi = "10.2217/epi-2023-0164",

language = "English",

volume = "15",

pages = "693--703",

journal = "Epigenomics",

issn = "1750-1911",

number = "13",

}

Joyce, BT, Chen, X, Gao, T, Zheng, Y, Nannini, DR, Liu, L, Henkle, BE, Kalhan, R, Washko, G, Kunisaki, KM, Thyagarajan, B, Vaughan, DE, Gross, M, Jacobs, DR, Lloyd-Jones, D & Hou, L 2023, 'Associations between GrimAge acceleration and pulmonary function in the Coronary Artery Risk Development in Young Adults (CARDIA) study', Epigenomics, vol. 15, no. 13, pp. 693-703. https://doi.org/10.2217/epi-2023-0164

TY - JOUR

T1 - Associations between GrimAge acceleration and pulmonary function in the Coronary Artery Risk Development in Young Adults (CARDIA) study

AU - Joyce, Brian T.

AU - Chen, Xuefen

AU - Gao, Tao

AU - Zheng, Yinan

AU - Nannini, Drew R.

AU - Liu, Lei

AU - Henkle, Benjamin E.

AU - Kalhan, Ravi

AU - Washko, George

AU - Kunisaki, Ken M.

AU - Thyagarajan, Bharat

AU - Vaughan, Douglas E.

AU - Gross, Myron

AU - Jacobs, David R.

AU - Lloyd-Jones, Donald

AU - Hou, Lifang

PY - 2023/7/1

Y1 - 2023/7/1

N2 - Background: The objective of this research was to determine whether pulmonary function is associated with epigenetic aging (GrimAge) and whether GrimAge predicts emphysema. Methods: This prospective study examined 1042 participants enrolled as part of a community-based longitudinal cohort. The cross-sectional associations between pulmonary function and GrimAge, measured at study year (Y) 20 (participant ages 40-45 years), and prospective associations with emphysema at Y25 were examined. Results: At Y20, forced expiratory volume in 1 s (FEV1) and FEV1/forced vital capacity (FVC) were negatively associated with GrimAge; for Y0-Y10 cumulative measures, only the FEV1/FVC ratio was associated with GrimAge at Y15 and Y20. Emphysema at Y25 was associated with GrimAge at Y15 and Y20. Conclusion: Pulmonary function was associated with GrimAge during early and mid-life; GrimAge partially mediated the association between pulmonary function and emphysema.

AB - Background: The objective of this research was to determine whether pulmonary function is associated with epigenetic aging (GrimAge) and whether GrimAge predicts emphysema. Methods: This prospective study examined 1042 participants enrolled as part of a community-based longitudinal cohort. The cross-sectional associations between pulmonary function and GrimAge, measured at study year (Y) 20 (participant ages 40-45 years), and prospective associations with emphysema at Y25 were examined. Results: At Y20, forced expiratory volume in 1 s (FEV1) and FEV1/forced vital capacity (FVC) were negatively associated with GrimAge; for Y0-Y10 cumulative measures, only the FEV1/FVC ratio was associated with GrimAge at Y15 and Y20. Emphysema at Y25 was associated with GrimAge at Y15 and Y20. Conclusion: Pulmonary function was associated with GrimAge during early and mid-life; GrimAge partially mediated the association between pulmonary function and emphysema.

KW - DNA methylation age

KW - aging

KW - emphysema

KW - lung function

KW - methylation

UR - http://www.scopus.com/inward/record.url?scp=85173216288&partnerID=8YFLogxK

U2 - 10.2217/epi-2023-0164

DO - 10.2217/epi-2023-0164

M3 - Article

C2 - 37694401

AN - SCOPUS:85173216288

SN - 1750-1911

VL - 15

SP - 693

EP - 703

JO - Epigenomics

JF - Epigenomics

IS - 13

ER -

Associations between GrimAge acceleration and pulmonary function in the Coronary Artery Risk Development in Young Adults (CARDIA) study

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this